<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta />
    <article-meta>
      <title-group>
        <article-title>Adaptive Recommendations for Patients with Diabetes</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>Stephan Weibelzahl</string-name>
          <email>weibelzahl@pfh.de</email>
          <xref ref-type="aff" rid="aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Dominikus Heckmann</string-name>
          <email>d.heckmann@oth-aw.de</email>
          <xref ref-type="aff" rid="aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Eelco Herder</string-name>
          <email>herder@l3s.de</email>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Karsten Mussig</string-name>
          <email>Karsten.Muessig@DDZ.uni-duesseldorf.de</email>
          <xref ref-type="aff" rid="aff0">0</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Janko Schildt</string-name>
          <email>j.schildt@emperra.com</email>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>Department of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University</institution>
          ,
          <addr-line>Dusseldorf</addr-line>
          ,
          <country country="DE">Germany</country>
        </aff>
        <aff id="aff1">
          <label>1</label>
          <institution>Emperra E-Health Technologies GmbH</institution>
          ,
          <country country="DE">Germany</country>
        </aff>
        <aff id="aff2">
          <label>2</label>
          <institution>German Center for Diabetes Research</institution>
          ,
          <addr-line>Partner Dusseldorf</addr-line>
          ,
          <country country="DE">Germany</country>
        </aff>
        <aff id="aff3">
          <label>3</label>
          <institution>Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research</institution>
          ,
          <addr-line>Dusseldorf</addr-line>
          ,
          <country country="DE">Germany</country>
        </aff>
        <aff id="aff4">
          <label>4</label>
          <institution>L3S Research Center, Leibniz University Hannover</institution>
          ,
          <country country="DE">Germany</country>
        </aff>
        <aff id="aff5">
          <label>5</label>
          <institution>Ostbayerische Technische Hochschule Amberg-Weiden</institution>
          ,
          <country country="DE">Germany</country>
        </aff>
        <aff id="aff6">
          <label>6</label>
          <institution>PFH Private University of Applied Sciences Gottingen</institution>
          ,
          <country country="DE">Germany</country>
        </aff>
      </contrib-group>
      <abstract>
        <p>Diabetes mellitus is a major epidemic with about 8.3% of the world population being a ected. Proper treatment minimizes the risk of secondary diseases. The GlycoRec system aims to support patients in making decision that are related to the treatment by modeling their behavior and their physiology. Here we describe the aims and rst steps towards the development of GlycoRec.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>-</title>
      <p>
        Diabetes mellitus is a major epidemic and a threat to public health with about
8.3% of the world adult population being a ected (Shi &amp; Hu, 2014). The
highest increase in diagnoses in recent years is observed in patients aged 60 and
over. While there is no known cure for diabetes, it can be managed through
a combination of diet, exercise and appropriate medication. However, when not
managed in an appropriate way, patients are at high risk of developing secondary
conditions comprising in particular as cardiovascular disease resulting in a
signi cantly increased morbidity and mortality. Therefore, it is of high importance
that patients are able to manage their diabetes treatment on their own aiming
at near normal blood glucose levels
        <xref ref-type="bibr" rid="ref1">(American Diabetes Association, 2014)</xref>
        .
      </p>
      <p>Most patients who treat their diabetes with insulin go through the same
routine several times each day: they monitor their current blood glucose level using a
glucometer; they estimate their carbohydrate intake; they calculate the required
insulin doses and inject an appropriate amount. Di erent types of insulin that
vary in onset and duration of action may be used.</p>
      <p>
        One of the challenges in diabetes management is the patients' need to learn
how their body reacts to food intake, activity and insulin application. Mobile
apps currently available for calculating insulin dose without reference to
individual needs show systemic issues such as missing validity checks of input data
a ecting the safety of patients
        <xref ref-type="bibr" rid="ref5">(Huckvale, Adomaviciute, Prieto, Leow, &amp; Car,
2015)</xref>
        .
2
      </p>
    </sec>
    <sec id="sec-2">
      <title>Aims and Objectives</title>
      <p>The GlycoRec system aims to support diabetes patients in managing their
disease. It supports decisions and gives individualized recommendations based on
the patient's behavior, physiology and treatment history. Individualized advise
may include
{ estimation of nutritional characteristics such as carbohydrate content and
glycemic index of meals
{ recommendations on insulin application based on glucose level, activity and
food intake
{ warnings if blood glucose levels are at risk of leaving the target range
3</p>
    </sec>
    <sec id="sec-3">
      <title>Requirements Engineering</title>
      <p>
        Complex adaptive interactive systems such as GlycoRec require systematic
elicitation and documentation of requirements
        <xref ref-type="bibr" rid="ref4">(Gena &amp; Weibelzahl, 2007)</xref>
        .
3.1
      </p>
      <sec id="sec-3-1">
        <title>Requirements Elicitation</title>
        <p>
          Based on an extensive review of the literature, we designed a survey for patients
to explore both the patients' situation as well as the main barriers they
encounter. Questions on the patients' current situation referred to their strategies
for managing their disease as well as the technologies available to them. The
exploration of barriers encountered will help to tailor functionality to patients and
prioritize features. Moreover, semi-structured interviews with diabetes nurses
will be conducted in order to validate the survey results and to elicit expert
knowledge on diabetes management strategies
          <xref ref-type="bibr" rid="ref3">(Dix, Finlay, Abowd, &amp; Beale,
1998; Weibelzahl, Jedlitschka, &amp; Ayari, 2006)</xref>
          .
3.2
        </p>
      </sec>
      <sec id="sec-3-2">
        <title>Preliminary Personas</title>
        <p>
          In order to support the modeling process, we developed a set of personas
          <xref ref-type="bibr" rid="ref2">(Cooper,
1999)</xref>
          that represent the main target groups of the system in regard to their needs
and preferences. Figure 1 shows a condensed version of two of the personas
developed based on the survey data.
{ male, age 59
{ accountant
{ type 2 diabetes
{ diagnosed 12 months ago
{ owns smart phone
{ likes to prepare his own
        </p>
        <p>meals
{ has lunch in company's
cafe</p>
        <p>teria
{ feels insecure when taking
treatment decisions</p>
      </sec>
    </sec>
    <sec id="sec-4">
      <title>Beate</title>
      <p>{ female, age 30
{ shop assistant
{ type 1 diabetes
{ diagnosed at age 6
{ uses smart phone and tablet</p>
      <p>PC on regular basis
{ long-standing experience</p>
      <p>with diabetes management
{ focus on healthy life-style,</p>
      <p>exercises three times a week
{ wants exibility, e.g., eat out,</p>
      <p>clubbing
The GlycoRec architecture follows the high level pattern of interactive adaptive
systems in accordance with Jameson (2008) comprising inference, modeling and
adaptation decision. Figure 2 depicts an outline of the high-level system
architecture. A variety of sensor data are collected including actual glucose level as
measured by a glucometer, level of activity and insulin application. Data are
gathered through smart phone, smart watch and networked glucometer and
insulin pen, stored in a central database and analyzed in order to model current
glucose level.</p>
      <p>Patients interact with the system via smart TV, tablet or smart watch. While
the smart watch interface is designed for interaction during the day where both
the patient and the system can initiate interaction, the smart TV interface
supports review and re ection on historical data and facilitates identi cation of
patterns over time. Patients can also share their records with their physician or
their diabetes nurse for discussion of their diabetes management.
5</p>
    </sec>
    <sec id="sec-5">
      <title>User Modeling and Adaptation</title>
      <p>From a user modeling perspective, GlycoRec tackles a number of challenges,
including but not limited to:</p>
      <p>Firstly, physical reactions to insulin, food intake and activity in diabetes are
idiosyncratic. While the general patterns are known, individual patients seem
to respond di erently in similar situations, depending on factors such as age,
weight, general heath, medication, comorbidities, to name but a few. Individual
response patterns need to be observed and learned.</p>
      <p>Secondly, this will involve combining a variety of sensor data. We have
selected a number of candidates, but it will be necessary to narrow down the list
for both modeling and practical reasons.</p>
      <p>Thirdly, the available data vary greatly in granularity and quality. While for
instance activity level can be assessed on a continuous basis, most patients
measure their glucose level three to seven times a day, with some patients measuring
only once a day. So while validation and readjustment of glucose level measures
are sparse, the (predicted) glucose level need to be assessed at any time in
order to be able to issue warnings. Accordingly, models will di er in certainty at
di erent points in time.</p>
      <p>
        Fourthly, the development process is subject to a number of regulations, as
any device involved in the treatment of patients is considered a medical device
that needs to be compliant with ISO 13485
        <xref ref-type="bibr" rid="ref6">(International Standards
Organization, 2003)</xref>
        . User testing and iterative development is less exible under these
conditions.
      </p>
      <p>Lastly, designing the adaptive user experience for patients is challenging as
the disease has huge impact on the patients' lives anyway. Any additional e ort
and new processes in managing their disease will only be accepted if the bene ts
are obvious and the required input is minimal, i.e., data collection and modeling
need to happen with minimal or no user interaction in the background, but if
and only if intervention is required the system needs to take initiative and make
reliable recommendations.
6</p>
    </sec>
    <sec id="sec-6">
      <title>Future Perspectives</title>
      <p>This three-year project commenced in January 2015 and is in its early stages.
Requirements have been gathered. Signi cant involvement of patients in the
development process and the application of further user centered design methods
(Norman, 1988) is planned for the next phase. A user evaluation including
validation against physiological parameters of treatment quality such as the HbA1c
value (Larsen, H rder, &amp; Mogensen, 1990) will demonstrate the e ects of the
system.</p>
    </sec>
    <sec id="sec-7">
      <title>Acknowledgment References</title>
      <p>The GlycoRec project is funded by the Federal Ministry of Education and
Research (BMBF) under the funding scheme Adaptive, Learning Systems
(Adaptive, lernende Systeme).</p>
      <p>Jameson, A. (2008). Adaptive user interfaces and agents. In A. Sears &amp; J. Jacko
(Eds.), The human-computer interaction handbook: Fundamentals,
evolving technologies and emerging applications (2nd ed., pp. 433{458). Boca
Raton, FL: CRC Press.</p>
      <p>Larsen, M. L., H rder, M., &amp; Mogensen, E. F. (1990). E ect of
longterm monitoring of glycosylated haemoglobin levels in insulin-dependent
diabetes mellitus. N. Engl. J. Med., 323 (15), 1021{1025. doi:
10.1056/NEJM199010113231503
Norman, D. (1988). The design of everyday things. New York: Basic Books.
Shi, Y., &amp; Hu, F. B. (2014). The global implications of diabetes and cancer. The</p>
      <p>Lancet, 383 (9933), 1947|1948. doi: 10.1016/S0140-6736(14)60886-2
Weibelzahl, S., Jedlitschka, A., &amp; Ayari, B. (2006). Eliciting requirements for an
adaptive decision support system through structured user interviews. In
Proceedings of the Fifth Workshop on User-Centred Design and Evaluation
of Adaptive Systems, held in conjunction with the 4th International
Conference on Adaptive Hypermedia &amp; Adaptive Web-based Systems (AH'06),
Dublin, Ireland, 20 June 2006 (pp. 770{778). Dublin: National College of
Ireland.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          <string-name>
            <surname>American Diabetes Association.</surname>
          </string-name>
          (
          <year>2014</year>
          ).
          <article-title>Standards of medical care in diabetes 2014</article-title>
          .
          <source>Diabetes Care</source>
          ,
          <volume>37</volume>
          (
          <issue>suppl 1</issue>
          ), S14{
          <fpage>S80</fpage>
          . doi:
          <volume>10</volume>
          .2337/dc14-S014
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          <string-name>
            <surname>Cooper</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          (
          <year>1999</year>
          ).
          <article-title>The inmates are running the asylum: Why high-tech products drive us crazy and how to restore the sanity</article-title>
          . Indianapolis, IN: SAMS.
        </mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation>
          <string-name>
            <surname>Dix</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Finlay</surname>
            ,
            <given-names>J. E.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Abowd</surname>
            ,
            <given-names>G. D.</given-names>
          </string-name>
          , &amp;
          <string-name>
            <surname>Beale</surname>
            ,
            <given-names>R.</given-names>
          </string-name>
          (
          <year>1998</year>
          ).
          <article-title>Human computer interaction (2nd ed</article-title>
          .). Harlow, UK: Prentice Hall.
        </mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation>
          <string-name>
            <surname>Gena</surname>
            ,
            <given-names>C.</given-names>
          </string-name>
          , &amp;
          <string-name>
            <surname>Weibelzahl</surname>
            ,
            <given-names>S.</given-names>
          </string-name>
          (
          <year>2007</year>
          ).
          <article-title>Usability engineering for the adaptive web</article-title>
          . In P. Brusilovsky,
          <string-name>
            <given-names>A.</given-names>
            <surname>Kobsa</surname>
          </string-name>
          , &amp; W. Nejdl (Eds.),
          <source>The Adaptive Web: Methods and Strategies of Web Personalization</source>
          (pp.
          <volume>720</volume>
          {
          <fpage>762</fpage>
          ). Berlin: Springer. doi:
          <volume>10</volume>
          .1007/978-3-
          <fpage>540</fpage>
          -72079-9 24
        </mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation>
          <string-name>
            <surname>Huckvale</surname>
            ,
            <given-names>K.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Adomaviciute</surname>
            ,
            <given-names>S.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Prieto</surname>
            ,
            <given-names>J. T.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Leow</surname>
          </string-name>
          ,
          <string-name>
            <surname>M. K.-S.</surname>
          </string-name>
          , &amp;
          <string-name>
            <surname>Car</surname>
            ,
            <given-names>J.</given-names>
          </string-name>
          (
          <year>2015</year>
          ).
          <article-title>Smartphone apps for calculating insulin dose: a systematic assessment</article-title>
          .
          <source>BMC Medicine</source>
          ,
          <volume>13</volume>
          , 106. doi:
          <volume>10</volume>
          .1186/s12916-015-0314-7
        </mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation>
          <string-name>
            <surname>International Standards Organization.</surname>
          </string-name>
          (
          <year>2003</year>
          ). ISO 13485:
          <year>2003</year>
          {
          <article-title>Medical devices { Quality management systems { Requirements for regulatory purposes (2nd ed</article-title>
          .). Geneva, Switzerland: ISO.
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>